As of 2024-12-15, the Relative Valuation of NeonMind Biosciences Inc (NEON.CN) is (0.04) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.14 CAD, the upside of NeonMind Biosciences Inc based on Relative Valuation is -131.1%.
The range of the Relative Valuation is (0.03) - (0.05) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.0x - 0.1x | 0.0x |
| Forward P/E multiples | 0.0x - 0.1x | 0.0x |
| Fair Price | (0.03) - (0.05) | (0.04) |
| Upside | -124.9% - -137.3% | -131.1% |
| Date | P/E |